The case series conducted by Eger et al. [24] sheds light on this issue, where four patients, previously treated with anti-IL-5 or anti-IL-5R biologics for oral corticosteroid (OCS)-dependent asthma, switched to Dupilumab. This evidence concerns the gene IL5 and asthma.